Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Bilayer Tablets-A Review


Affiliations
1 Acharya Nagarjuna University College of Pharmaceutical Sciences, Guntur, India
     

   Subscribe/Renew Journal


Bi-layer tablet is a new era for successful development of controlled release formulation along with various features to provide successful drug delivery. Bilayer tablet technology helps in separating the two incompatible substances in which one layer is immediate release as loading dose and second layer is controlled/sustained release as maintenance dose. A Delayed Release dosage form is designed to release the drug at a time other than promptly after administration.The primary aim of using delayed release products is to protect the drug from gastric fluids, to reduce gastric distress caused by drugs particularly irritating to the stomach or to facilitate gastrointestinal transit for drugs that are better absorbed from intestine. Delayed Release products are typically enteric-coated or targeted to the colon. It is fabricated by coating the drug only in the region with a selected pH range It is fabricated by coating the drug-containing core with a PH sensitive polymer combination. It is fabricated by coating the drug only in the region with a selected pH range, Further best formulation is subjected to dissolution studies first in 0.1N HCL buffer for 2hrs followed by phosphate buffer for 4 hrs.

Keywords

Bilayer, Acid Labile, Control Release, Delayed Release, Enteric Coated.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Bilayer tablet-www.rroij.com/open-access/A-review-on-bilayered-tablets-php? aid=78042
  • Anusha jsk et al, A review on Bilayer tablets, Journal of pharmacy and pharmaceutical sciences,volume-5, pg:118-121
  • Siva sai kiran etal, review on bilayer tablets, International Journal of Pharmaceutical chemistry and biological sciences, pg: 510-516.
  • Neha p. singh et al , review on bilayer tablets, World Journal of Pharmacy and Pharmaceutical sciences,volume-4, pg, 703-717
  • Verma rameshwar et al, Bilayer tablets for various drugs, scholars academic Journal of Pharmacy, pg-271-279
  • ww.pharmachitchat.com/oral-controlled-release-drug-delivery-areview/
  • www.pharmamirror.com/knowledge-base/pharmaceutical-dictionary/delayed-release-drug-delivery
  • https://www.ncbi.n/m.nih.gov/pmc/articles/pmc2974120/
  • Shodhganga.inflibnet.ac.in/bitstream/10603/70474/13/13_chapter_4.pdf
  • Shodhganga.inflibnet.ac.in/bit stream/10603/41588/6/4%20drug%20profile.pdf
  • www.ijddr.in/drug-development/formulation-development and-evaluation-of delayed-release tablets

Abstract Views: 183

PDF Views: 0




  • Bilayer Tablets-A Review

Abstract Views: 183  |  PDF Views: 0

Authors

U. Annapurna
Acharya Nagarjuna University College of Pharmaceutical Sciences, Guntur, India
K. Sai Priyanka
Acharya Nagarjuna University College of Pharmaceutical Sciences, Guntur, India

Abstract


Bi-layer tablet is a new era for successful development of controlled release formulation along with various features to provide successful drug delivery. Bilayer tablet technology helps in separating the two incompatible substances in which one layer is immediate release as loading dose and second layer is controlled/sustained release as maintenance dose. A Delayed Release dosage form is designed to release the drug at a time other than promptly after administration.The primary aim of using delayed release products is to protect the drug from gastric fluids, to reduce gastric distress caused by drugs particularly irritating to the stomach or to facilitate gastrointestinal transit for drugs that are better absorbed from intestine. Delayed Release products are typically enteric-coated or targeted to the colon. It is fabricated by coating the drug only in the region with a selected pH range It is fabricated by coating the drug-containing core with a PH sensitive polymer combination. It is fabricated by coating the drug only in the region with a selected pH range, Further best formulation is subjected to dissolution studies first in 0.1N HCL buffer for 2hrs followed by phosphate buffer for 4 hrs.

Keywords


Bilayer, Acid Labile, Control Release, Delayed Release, Enteric Coated.

References